HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Telatinib

HCID 9808844
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
332012-40-5
Standard SMILES
CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1
InChIKey
QFCXANHHBCGMAS-UHFFFAOYSA-N
Molecular formula
C20H16ClN5O3
Average molar mass
409.8 g/mol
Monoisotopic mass
409.0941671

Overview

Telatinib is a member of the class of furopyridazines that is furo[2,3-d]pyridazine substituted by (4-chlorophenyl)amino and [2-(methylcarbamoyl)pyridin-4-yl]methoxy groups at positions 4 and 7, respectively. It is a potent inhibitor of VEGFR2/3, c-Kit and PDGFRalpha. It has a role as an antineoplastic agent, an angiogenesis inhibitor, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, a vascular endothelial growth factor receptor antagonist and an apoptosis inducer. It is a member of anilines, a furopyridazine, a pyridinecarboxamide, an aromatic ether and a member of monochlorobenzenes.

Names & identifiers

Preferred name
Telatinib
IUPAC
4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide
English name
Telatinib
Molecular formula
C20H16ClN5O3
Molecular weight
409.83

Names & synonyms

Telatinib332012-40-5Bay 57-9352BAY-579352telatinibumBAY-57-93524-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide18P7197Q7J4-(((4-((4-CHLOROPHENYL)AMINO)FURO(2,3-D)PYRIDAZIN-7-YL)OXY)METHYL)-N-METHYLPYRIDINE-2-CARBOXAMIDE4-((4-(4-chloroanilino)furo(2,3-d)pyridazin-7-yl)oxymethyl)-N-methylpyridine-2-carboxamideRefChem:187740Telatinib [INN]
Show more names
CS-361CS-1854TelatnibUnii-18p7197Q7jTelatinib USP/EP/BPTelatinib, 10 mM in DMSOnaproxen sodium + caffeine4-((4-(4-chlorophenylamino)furo[2,3-d]pyridazin-7-yloxy)methyl)-N-methylpicolinamide
4-(((4-((4-chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide4-[[4-(4-Chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methyl-pyridine-2-carboxamideMFCD18251453Telatinib(BAY 57-9352)CHEMBL20795884-({[4-(4-Chloroanilino)furo[2,3-d]pyridazin-7-yl]oxy}methyl)-N-methylpyridine-2-carboxamide2-Pyridinecarboxamide, 4-(((4-((4-chlorophenyl)amino)furo(2,3-d)pyridazin-7-yl)oxy)methyl)-N-methyl-Telantinib

Properties

Computed structural properties

XLogP
3.1
Topological polar surface area
102 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
7
Rotatable bonds
6
Heavy atoms
29
Formal charge
0
Complexity
548

Physicochemical properties

Boiling point
713.6 · 713.6±60.0 °C(Predicted)
Density
1.417 · 1.417
storage temp.
-20 °C · Store at -20°C
solubility
2 O; · insoluble in H2O; insoluble in EtOH; ≥20.5 mg/mL in DMSO
form
solid
pka
14.18 · 14.18±0.46(Predicted)
color
White to light yellow
InChI
InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)
InChIKey
QFCXANHHBCGMAS-UHFFFAOYSA-N
SMILES
C1(C(NC)=O)=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3C=COC2=3)=C1
FDA UNII
18 P7197Q7J · 18P7197Q7J
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P403+P233-P405-P501

Chemistry & industry

Applications · 3 items

DescriptionTelatinib is a multi-kinase inhibitor that inhibits VEGF receptor 2 (VEGFR2), VEGFR3, PDGFRα, and c-Kit (IC50s = 6, 4, 15, and 1 nM, respectively). It also binds to the transmembrane region of the ABCG2 efflux transporter and enhances intracellular accumulation of [3H]-mitoxantrone in ABCG2-overexpressing cells. Telatinib (15 mg/kg) decreases tumor growth rate and size in an H460/MX20 mouse xenograft model.

UsesTelatinib small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases. Telatinib is used therapeutically in patients with advanced solid tumors.

UsesTelatinib (BAY 57-9352) is an orally available, potent multitargeted VEGFR-2, VEGFR-3, PDGFR-β and c-Kit tyrosine kinases inhibitor with an IC50 of 19 nM for the inhibition of VEGFR-2 autophosphorylation.

Upstream & downstream products

Upstream raw materials

Furo[2,3-d]pyridazin-7-amine, 4-chloro-N-(4-chlorophenyl)-Furo[2,3-d]pyridazine, 4,7-dichloro4-(hydroxymethyl)-N-methylpicolinamideFuran-2,3-dicarboxylic acid(2-Methylaminocarbonyl-4-pyridyl)methanol2-Methylcarbamoylisonicotinic acid ethyl esterFuro[2,3-d]pyridazin-4-amine, 7-chloro-N-(4-chlorophenyl)-

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
332012-40-5
PubChem CID
9808844
DTXSID
DTXSID70954809
ChEMBL
CHEMBL2079588
ChEBI
CHEBI:231351
UNII
18P7197Q7J
261 · P261-P264-P270-P271-P280-P301+P312-P330-P302+P352-P321-P304+P340-P305+P351+P338-P332+P313-P362+P364-P337+P313-P403+P233-P405-P501
5,6-dihydrofuro[3,2-d]pyridazine-4,7-dione
2,3-furandicarboxylic acid dimethyl ester
3-Furoic acid
N-Methylformamide
Ethyl isonicotinate